Recently, the Second Circuit, Sixth Circuit, and a Texas district again rejected the pharmaceutical industry’s challenges to ...

NORTH CHICAGO, Ill., Aug. 19, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Capstan Therapeutics. With the completion of the acquisition, Capstan is ...

AbbVie Inc. has turned heads recently with a notable uptick in stock searches. Over the last month, its shares soared by +9.2 ...

Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in th ...

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Over the past decade, AbbVie's shares have increased by 353.3%, or 16.3% annually, with dividends reinvested. That's ...

Glenmark Pharmaceuticals to close ISB 2001 transaction in September, focusing on high-margin branded products for growth.

Analysts are intrested in these 5 stocks: ( ($ABBV) ), ( ($DOW) ), ( ($KTOS) ), ( ($RKT) ) and ( ($AMAT) ). Here is a breakdown of their recent ...

AbbVie Inc. is in the spotlight as Cantor Fitzgerald revises its FY2025 EPS forecast upwards. Analysts now anticipate $12.05 ...

In ancient Celtic folklore, Tír na nÓg is the land of eternal youth, where time stands still and people don’t age. Today, in the west of Ireland, they’ve come close to bottling it. Westport, a small ...

The global biopharma firm will build a new API production facility near its global headquarters in North Chicago.